$1.45
0.1712.89%
Last update: Aug 25, 10:15 AM
Pacific Biosciences of California Inc Earnings Estimates
PACBNASDAQ
Pacific Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:PACB
Pacific Biosciences (PACB) is scheduled to report Q3 earnings on November 4, 2026. Analysts estimate EPS of $-0.13 and quarterly revenue of $38.92M.
In the most recent quarter (Q2), Pacific Biosciences reported EPS of $-0.14, missing estimates of $-0.13 by 0.08%. Revenue came in at $39.01M, missing the estimate of $40.97M by 0.05%.
Over the last 4 quarters, Pacific Biosciences has averaged an EPS surprise of 0.17% and a revenue surprise of 0.06%.
Earnings Date
Nov 4
EPS Estimate
$-0.130
Quarterly Revenue Estimate
$38.92M
Annual Revenue
$159.27M
as of Jun 30
Pacific Biosciences Earnings History
Analyze the earnings history of Pacific Biosciences using advanced sorting and filters.
Pacific Biosciences (PACB) Earnings Per Share
The chart below shows Pacific Biosciences's reported EPS compared to analyst estimates over recent quarters.
Pacific Biosciences (PACB) Revenue
The chart below shows Pacific Biosciences's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences (PACB) is scheduled to report earnings on November 4, 2026. The last reported earnings were for reported on August 5, 2026 for Q2.
What were the latest earnings per share (EPS) for Pacific Biosciences (NASDAQ:PACB)?
The Actual EPS was $-0.14, which missed the estimate of $-0.13.
What were Pacific Biosciences’s (NASDAQ:PACB) revenues?
The Actual Revenue was $39.01M, which missed the estimate of $40.97M.
